Navigation Links
California Life Science, Business, and Economic Development Experts Discuss California's Bioscience Future
Date:8/26/2009

MENLO PARK, Calif., Aug. 26 /PRNewswire-USNewswire/ -- Today a group of national and California-based partners hosted the California Bioscience Business Roundtable (BBR) event at the Quadrus Conference Center in Menlo Park. The event also featured Sam Youngman, the White Correspondent for The Hill newspaper, who provided a reporter's front row perspective on the unfolding health reform debate in Washington, D.C.

Bioscience represents a major source of potential economic development in California. In 2007, nearly 271,000 people were directly employed by the industry (California Biomedical Industry 2009 Report, California Health Institute).

BBR is a unified voice of leaders representing the biotechnology, life sciences, and biomedical research industries -- collectively known as the bioscience community. Its mission is to promote public policies that on a local, state and federal level safeguard and sustain America's place as the world leader in bioscience. The three tenets of BBR are to promote access, prevention and encourage innovation. This is achieved by building bridges of understanding between government leaders, the business community and academia on key issues facing California and the United States' dynamic bioscience community.

"California's life sciences community is committed to continued leadership, as evidenced by the wide-ranging groups in attendance here today. Academic and medical research institutions, small and large manufacturing enterprises, and the businesses that support health innovation are all gathered to learn more about what we can do to partner with the government going forward," said Matt Gardner, President and CEO of BayBio. "California already has the infrastructure in place to ensure economic growth in the life sciences sector. Open exchanges of ideas, such as today's forum, are essential to making sure that Californians benefit from the investments in treatments, cures and technologies taking place here in Silicon Valley and throughout the state."

Partners hosting today's event included: BayBio, Bay Area Economic Institute, BIOCOM, California Healthcare Institute, California Manufacturers & Technology Association, Los Altos Chamber of Commerce, San Jose-Silicon Valley Chamber of Commerce, Santa Clara Chamber of Commerce & Convention-Visitors Bureau, Stanford School of Medicine Career Center, Mountain View Chamber of Commerce, the Biotechnology Industry Organization (BIO), the National Venture Capital Association (NVCA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and the U.S. Chamber of Commerce.

For more information please visit www.californiabbr.org.


'/>"/>
SOURCE California Bioscience Business Roundtable
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. California Bioscience Business Roundtable Aug. 26th
2. Two University of Southern California Innovators Recognized by Technology Reviews Prestigious TR35 Listing of the Worlds Top Young Innovators for 2009
3. Genoptix Announces Participation at the 2009 Southern California Investor Conference
4. ClinfoSource and California State University, East Bay Jointly Launch On-Line Certificate Program in Clinical Research
5. UCLA welcomes startup to new incubator space at California NanoSystems Institute
6. GreenHouse Energy, Governor Schwarzenegger Join in Driving the Future of Fueling in California
7. Horizon Therapeutics Selected to Present at InsideVentures Debut Investor Conference March 25-26, Santa Barbara, California
8. California Grants SeqWright License to Operate as a Clinical Laboratory
9. Transgenomic Awarded Clinical Laboratory Certification in California
10. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
11. Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, into ... for over 35 years, is proud to add Target to its list of ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):